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Inhibiting the growth of malignant melanoma by blocking the expression of
vascular endothelial growth factor using an RNA interference approach
Recent studies suggest overexpression of VEGF is observed and correlated with tumour
angiogenesis, progression and metastasis and poor outcome in solid human tumours,
including malignant melanoma. RNA interference technique has become a new and
hot research ﬁeld for gene therapy because it can block the target gene expression
efﬁciently and speciﬁcally. Tao et al have constructed pU-VEGF-siRNA plasmid and
transferred it into malignant melanoma cell line A375. The delivery of siRNA directed
against VEGF was shown to not only efﬁciently and speciﬁcally down-regulate the
expression of VEGF, inhibit proliferation of A375 and induce apoptosis of A375 cells
in vitro, but also suppress growth of malignant melanoma in vivo. These results suggested
that siRNA-based targeting VEGF strategy may build the foundation to the clinical
management of malignant melanoma.
Tao J, Tu Y-T, Huang C-Z et al. Inhibiting the growth of malignant melanoma by
blocking the expression of vascular endothelial growth factor using an RNA
interference approach. Br J Dermatol 2005; 153: 715–724.
DHCR7 mutations cause photosensitive Smith-Lemli-Opitz syndrome
Smith-Lemli-Opitz syndrome (SLOS) is an autosomal recessive malformation caused b
7-dehydrocholesterol reductase mutations (DHCR7 gene). Photosensitivity is a feature
of some, but not all, SLOS patients. Anstey et al have investigated if photosensitive
patients share speciﬁc DHCR7 mutations. Fifteen samples from ﬁve SLOS families with
severe photosensitivity were screened using PCR and automated sequencing. Five
different missense mutations (P51H, T93M, L99P, E448K and R450L) and one splice
site mutation (IVS8-1 G>C: splice acceptor site) were found. All except P51H were
established DHCR7 mutations. It is concluded that SLOS with severe photosensitivity
is not caused by speciﬁc mutation in 7-dehydrocholesterol reductase.
Anstey AV, Azurdia AM, Rhodes LE et al. Photosensitive Smith-Lemli-Opitz syndrome
is not caused by a single gene mutation: analysis of the gene encoding
8-dehydrocholesterol reductase in ﬁve U.K. familes. Br J Dermatol 2005; 153: 774–779
Prenatal exclusion of harlequin ichthyosis; potential pitfalls in the timing of the
fetal skin biopsy
Harlequin ichthyosis (HI) is a severe and usually fatal congenital skin disorder. The
successful prenatal exclusion of HI in two fetuses from two independent families were
reported and the technical difﬁculties and potential pitfalls in the prenatal exclusion of
HI at early gestation stages were discussed. It was revealed that ultrastructural ﬁndings
obtained at around 19 weeks estimated gestational age (EGA) were not always
sufﬁcient for the prenatal diagnosis of HI. However, the morphology of lamellar
granules gives us useful and important information for HI prenatal diagnosis.
Shimizu A, Akiyama M, Ishiko A et al. Prenatal exclusion of harlequin ichthyosis;
potential pitfalls in the timing of the fetal skin biopsy Br J Dermatol 2005; 153:
811–814.
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